Sectors
Eight financial services firms holding stock in trading platform FXall made partial exits when it floated on Thursday, raising more than $62m from 5.2 million shares.
The Monsanto-backed biomass producer has lowered the range of its shares for its forthcoming IPO, with the mid-point decreasing from $22 to $16.50.
The Glaxo and Techne-backed biopharmaceutical firm dropped its price to $10 and issued an extra 500,000 shares prior to its flotation yesterday.
The online video platform developer, backed by a host of corporate investors, will price its shares at between $10 and $12 when it floats.
The waste conversion company is preparing a $125m initial public offering, with backers including Waste Management of Canada seeking a return on their investment.
The Fidelity-backed cancer drug developer has postponed its $191m IPO after setting the range, according to reports.
The computer security firm has raised $128m upon its flotation on NASDAQ, with Intel Capital garnering nearly $12m from the offering.
The internet services company will be floating at between $10 and $12 a share, with Intel Capital among the backers looking to cash in.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
